Allovir Email Format
Biotechnology Research
・
51-200 employees
・
Waltham, MA, USA
AlloVir is a biotechnology company developing novel allogeneic cell therapies to restore natural immunity against life-threatening viral diseases in immunocompromised patients.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@allovir.com
Company Overview
Industry
Biotechnology Research
Founded
2013
Headquarters
Waltham, MA, USA
Revenue
$10M-$25M
FUNDING Stage
Public
Website
Key Executives
Andrew Oxtoby (President and Chief Executive Officer), Brett Hagen (Chief Accounting Officer and Principal Financial Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Allovir?
Allovir uses the firstinitiallast format, so Jane Smith would be jsmith@allovir.com.
What type of therapies does Allovir specialize in developing?
Allovir specializes in allogeneic, off-the-shelf, virus-specific T cell therapies designed to restore natural immunity in severely immunocompromised patients, including those who have undergone hematopoietic cell transplants. The company was founded in 2013 out of Baylor College of Medicine research.
Who leads Allovir as its chief executive in 2026?
Andrew Oxtoby serves as President and Chief Executive Officer of Allovir, with Brett Hagen serving as Chief Accounting Officer and Principal Financial Officer.
How can I find and verify contact emails for Allovir employees?
Since Allovir uses the firstinitiallast@allovir.com pattern, you can construct most employee addresses directly. A tool like Clay can help you verify those addresses at scale and enrich your outreach list with additional contact details for Allovir staff.
Where is Allovir headquartered and how large is the company?
Allovir is headquartered at 1100 Winter Street in Waltham, Massachusetts, and has approximately 15 employees. The company trades on Nasdaq under the ticker ALVR and is part of the ElevateBio portfolio of cell and gene therapy companies.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating